Improving Dementia Policy Through Evidence-Based Economic Research

Robert J. Brent examines which dementia interventions provide benefits that justify their costs. Using large-scale NACC data, his research gives healthcare professionals, economists, and policymakers a clearer basis for deciding where public resources can make the greatest difference. 

robert j. brent

Robert J. Brent is Professor of Economics Emeritus at Fordham University in New York. His work focuses on cost-benefit analysis and its use in understanding difficult questions in healthcare and public policy. 

 

Much of his recent research examines dementia interventions through an economic lens. Using large-scale NACC data, he studies whether medical and non-medical interventions produce benefits that justify their costs. 

 

Through his books and published research, Brent aims to give researchers, healthcare professionals, economists, and policymakers clearer evidence for deciding which interventions deserve attention and public resources. 

Robert J. Brent:

Economist, Researcher & Author

About The Book

Robert J. Brent’s books examine dementia interventions through an economic lens, asking not only what works, but what is worth supporting with public funds.

Cost-Benefit Analysis and Dementia

NEW INTERVENTIONS

This first volume looks beyond medicine to examine practical interventions that may help people living with dementia. Robert J. Brent applies cost-benefit analysis to areas such as education, Medicare eligibility, hearing aids, vision correction, and alternatives to nursing-home care, considering how each intervention affects dementia symptoms and everyday functioning.

The book goes further than simply asking whether an intervention is effective. It also considers the economic value of the results, comparing benefits with costs to determine whether an intervention is socially worthwhile. This gives policymakers and healthcare decision-makers a more practical way to think about where limited public resources can be used most effectively.

Cost-Benefit Analysis and Dementia

Medicine Interventions

In Cost-Benefit Analysis and Dementia: Medicine Interventions, economist Robert J. Brent examines the economic and social value of commonly used medical interventions for people living with dementia. Drawing on data from the National Alzheimer’s Coordinating Center (NACC), the book applies cost-benefit analysis to five categories of medicines: FDA-approved dementia medications, beta-blockers, antipsychotics, nonsteroidal anti-inflammatory drugs (NSAIDs), and statins.

Moving beyond clinical effectiveness alone, Brent evaluates how these interventions affect dementia symptoms, mortality, life expectancy, and overall social welfare. The analysis offers a comparative perspective on which treatments may provide meaningful benefits relative to their costs and raises important questions about how limited healthcare resources should be allocated.

Explore Robert J. Brent’s Published Works

Research & Publications

Browse Robert J. Brent’s books and research on cost-benefit analysis, dementia interventions, healthcare policy, and the use of economic evidence in public decision-making.

cost-benefit analysis and dementia

2025

Lorem ipsum dolor sit amet, consectetur

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Sed do eiusmod tempor incididunt ut labore et dolore magna aliqua.

cost-benefit analysis and dementia

2025

Lorem ipsum dolor sit amet, consectetur

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Sed do eiusmod tempor incididunt ut labore et dolore magna aliqua.

cost-benefit analysis and dementia

2025

Lorem ipsum dolor sit amet, consectetur

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Sed do eiusmod tempor incididunt ut labore et dolore magna aliqua.

cost-benefit analysis and dementia

2025

Lorem ipsum dolor sit amet, consectetur

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Sed do eiusmod tempor incididunt ut labore et dolore magna aliqua.

cost-benefit analysis and dementia

2025

Lorem ipsum dolor sit amet, consectetur

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Sed do eiusmod tempor incididunt ut labore et dolore magna aliqua.

cost-benefit analysis and dementia

2025

Lorem ipsum dolor sit amet, consectetur

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Sed do eiusmod tempor incididunt ut labore et dolore magna aliqua.

Dementia Research, Economics and Public Policy

What Readers Are Saying

Connect with robert j. brent